Vincent J Willey

Summary

Affiliation: Health Outcomes Research
Country: USA

Publications

  1. ncbi Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting
    Vincent J Willey
    HealthCore, Inc, Wilmington, DE 19081, USA
    Clin Ther 26:1149-59. 2004
  2. ncbi Costs of severely ill members and specialty medication use in a commercially insured population
    Vincent J Willey
    Research Development and Operations, at HealthCore in Wilmington, Delaware, USA
    Health Aff (Millwood) 27:824-34. 2008
  3. ncbi Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Chaitanya A Sarawate
    Health Core, Inc, Wilmington, Delaware 19801, USA
    Clin Ther 29:196-209. 2007
  4. ncbi Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca LP, 800 Delaware Avenue, Wilmington, DE 19801, USA
    Am J Health Syst Pharm 64:276-84. 2007
  5. ncbi Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertension
    Michael F Bullano
    HealthCore Inc, Wilmington, Delaware 19801, USA
    Med Care 44:486-90. 2006
  6. ncbi Risk of cardiovascular events in patients at optimal values for combined lipid parameters
    Eric J Stanek
    Kos Pharmaceuticals, Inc, Cranbury, NJ, USA
    Curr Med Res Opin 23:553-63. 2007
  7. ncbi Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE 19850 5347, USA
    Am J Health Syst Pharm 63:2473-82. 2006
  8. ncbi Assessing incidence and economic burden of genital warts with data from a US commercially insured population
    Tracey Hoy
    HealthCore, Inc, Fifth Floor, 800 Delaware Avenue, Wilmington, DE 19801, USA
    Curr Med Res Opin 25:2343-51. 2009
  9. ncbi Risk of cardiovascular events and all-cause mortality in patients treated with thiazolidinediones in a managed-care population
    Debra A Wertz
    HealthCore, Inc, 800 Delaware Ave, 5th Floor, Wilmington, DE 19801, USA
    Circ Cardiovasc Qual Outcomes 3:538-45. 2010
  10. ncbi Monitoring anticoagulation in atrial fibrillation
    Chaitanya Sarawate
    HealthCore, 800 Delaware Ave 5th Floor, Wilmington, DE 19801, USA
    J Thromb Thrombolysis 21:191-8. 2006

Collaborators

Detail Information

Publications21

  1. ncbi Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting
    Vincent J Willey
    HealthCore, Inc, Wilmington, DE 19081, USA
    Clin Ther 26:1149-59. 2004
    ....
  2. ncbi Costs of severely ill members and specialty medication use in a commercially insured population
    Vincent J Willey
    Research Development and Operations, at HealthCore in Wilmington, Delaware, USA
    Health Aff (Millwood) 27:824-34. 2008
    ..The advantages of paying for specialty medications under the pharmacy benefit should be evaluated in conjunction with the potential consequences of increased out-of-pocket burden...
  3. ncbi Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Chaitanya A Sarawate
    Health Core, Inc, Wilmington, Delaware 19801, USA
    Clin Ther 29:196-209. 2007
    ..Published guidelines suggest the management of high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) values after the low-density lipoprotein cholesterol (LDL-C) goal is achieved...
  4. ncbi Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca LP, 800 Delaware Avenue, Wilmington, DE 19801, USA
    Am J Health Syst Pharm 64:276-84. 2007
    ..The effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein (LDL) cholesterol goals in patients treated in a usual care setting was studied...
  5. ncbi Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertension
    Michael F Bullano
    HealthCore Inc, Wilmington, Delaware 19801, USA
    Med Care 44:486-90. 2006
    ..This study evaluated the accuracy of 2 administrative claims-based selection rules to identify patients with hypertension (HTN) using medical records as the gold standard...
  6. ncbi Risk of cardiovascular events in patients at optimal values for combined lipid parameters
    Eric J Stanek
    Kos Pharmaceuticals, Inc, Cranbury, NJ, USA
    Curr Med Res Opin 23:553-63. 2007
    ..The study objective was to evaluate the risk of CV events in patients attaining versus not attaining combined (LDL-C, HDL-C, and TG) optimal lipid values...
  7. ncbi Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products
    Michael F Bullano
    Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE 19850 5347, USA
    Am J Health Syst Pharm 63:2473-82. 2006
    ..Rates of hypoglycemic events and their associated costs were compared among patients with type 2 diabetes mellitus newly initiated on insulin glargine or a premixed insulin fixed-combination product...
  8. ncbi Assessing incidence and economic burden of genital warts with data from a US commercially insured population
    Tracey Hoy
    HealthCore, Inc, Fifth Floor, 800 Delaware Avenue, Wilmington, DE 19801, USA
    Curr Med Res Opin 25:2343-51. 2009
    ..This study examined the incidence of and healthcare costs attributable to genital warts within a large US commercially insured, geographically dispersed population...
  9. ncbi Risk of cardiovascular events and all-cause mortality in patients treated with thiazolidinediones in a managed-care population
    Debra A Wertz
    HealthCore, Inc, 800 Delaware Ave, 5th Floor, Wilmington, DE 19801, USA
    Circ Cardiovasc Qual Outcomes 3:538-45. 2010
    ..This study directly compares risk of acute myocardial infarction (AMI), acute heart failure (AHF), or all-cause death among pioglitazone- and rosiglitazone-treated patients in a managed-care population...
  10. ncbi Monitoring anticoagulation in atrial fibrillation
    Chaitanya Sarawate
    HealthCore, 800 Delaware Ave 5th Floor, Wilmington, DE 19801, USA
    J Thromb Thrombolysis 21:191-8. 2006
    ....
  11. ncbi Statin safety: an assessment using an administrative claims database
    Mark J Cziraky
    HealthCore, Inc, Wilmington, Delaware 19801, USA
    Am J Cardiol 97:61C-68C. 2006
    ..No hospitalized cases of the index AEs were observed in study subjects during the 6-month period before initiation of the lipid-lowering drug. Statin monotherapy as currently prescribed is generally well tolerated and safe...
  12. ncbi Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention
    Louise J Short
    HealthCore, Inc, Wilmington, DE 19801 1366, USA
    Cancer 116:193-202. 2010
    ..African-American women have increased breast cancer mortality compared with white women. Diagnostic and treatment gaps may contribute to this disparity...
  13. ncbi Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting
    Michael F Bullano
    Health Outcomes Research, HealthCore, Inc, Wilmington, Delaware 19801, USA
    Pharmacotherapy 26:469-78. 2006
    ....
  14. ncbi Efficiency and economic benefits of a payer-based electronic health record in an emergency department
    Gregory W Daniel
    HealthCore, Inc, Wilmington, DE, USA
    Acad Emerg Med 17:824-33. 2010
    ....
  15. ncbi Beyond the myths: finding benefit design solutions that address the true costs of high healthcare use
    Vincent J Willey
    HealthCore, Wilmington, Delaware, USA
    Am J Manag Care 14:S252-63. 2008
    ..Achieving savings in direct and indirect costs will require more than shifting coverage, which can lead to nonadherence and increase costs elsewhere...
  16. ncbi Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products
    Michael F Bullano
    HealthCore, Inc, Wilmington, DE 19801, USA
    Curr Med Res Opin 21:291-8. 2005
    ..To compare hypoglycemia event rates in patients initiated on long-acting insulin analog (glargine) or intermediate-acting insulin (NPH) and to analyze the associated cost-consequence from a managed care perspective...
  17. ncbi Gender bias in lipid assessment and treatment following percutaneous coronary intervention
    Jennifer A Corbelli
    Buffalo Cardiology and Pulmonary Associates, 6460 Main St, Williamsville, NY 14231 9060, USA
    J Gend Specif Med 6:21-6. 2003
    ..To identify a possible gender bias in lipid assessment and treatment of patients following percutaneous coronary intervention (PCI)...
  18. ncbi Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, Virginia, USA
    Pharmacoeconomics 22:13-23. 2004
    ..The objective of this study was to determine whether lipid tests and physician visits after treatment initiation are indeed associated with adherence to statin therapy...
  19. ncbi Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting
    Lori Mosca
    Columbia University, New York, NY, USA
    Circulation 111:488-93. 2005
    ..This study evaluated optimal lipid-level attainment and treatment patterns on the basis of these guidelines in high-risk women in a managed care setting...
  20. ncbi Effects of gemfibrozil conversion to fenofibrate on lipids in patients on statin therapy
    John C Corbelli
    Buffalo Cardiology and Pulmonary Associates, Williamsville, New York 14231, USA
    Am J Cardiol 90:1388-91. 2002
  21. ncbi Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy
    Joshua S Benner
    ValueMedics Research, LLC, Falls Church, VA 22406, USA
    Am J Health Syst Pharm 62:1468-75. 2005
    ..The relationship between low-density lipoprotein (LDL) cholesterol reduction in the first 3 months of statin therapy and medication adherence during a 33-month follow-up period was studied...